Feb 18, 2026NMN vs NR vs Nicotinamide: First Direct Human Comparison of NAD+ PrecursorsA 2025 Nature Metabolism crossover trial directly compared NMN, NR, and nicotinamide in healthy adults. NMN and NR produced sustained blood NAD+ increases of 130–150%; nicotinamide produced only a transient 4-hour rise. Gut microbiome conversion was a key mechanistic finding.
Feb 10, 2026Nicotinamide Riboside and Nicotinamide: NAD+ Precursor Comparison and Human Trial EvidenceNicotinamide riboside (NR) and plain nicotinamide both raise NAD+ but through different pathways and with different safety profiles. NR has more published human trials; nicotinamide is cheaper but raises sirtuin-inhibition concerns at high doses.
Feb 9, 2026NAD+ Booster Comparison: NMN vs NR vs Nicotinamide — Absorption, Price, Evidence, and Practical ChoiceThree main NAD+ precursors dominate the market: NMN, NR, and nicotinamide (NAM). Each enters the NAD+ biosynthetic pathway at different points. Human trial data exist for all three. Cost and evidence quality vary substantially. This practical comparison helps readers choose rationally.